©The Author(s) 2025.
World J Gastroenterol. Dec 28, 2025; 31(48): 112653
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.112653
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.112653
Figure 5 Total headspace-gas chromatography-mass spectrometry data obtained for Crohn’s disease group of pediatric and adult patients.
A: Principal component analysis and Orthogonal Partial Least Squares Discriminant Analysis data represent two independent groups of samples [Crohn’s disease (CD)-kids, CD-adults]. According to the relative concentration of all detected volatile compounds; B: The nonparametric Mann-Whitney test was used for the primary comparisons between groups. Statistical significance was determined by a two-sided P-value of less than 0.05. False discovery rate correction was also applied; C: Box plots the quantitative differences in the relative contents of metabolites detected in the analyzed groups (CD-kids, CD-adults); D: Risk coefficient calculation. UC: Ulcerative colitis; CD: Crohn’s disease; PCA: Principal component analysis; IBD: Inflammatory bowel disease; OPLS-DA: Orthogonal Partial Least Squares Discriminant Analysis.
- Citation: Zakharzhevskaya NB, Erdes SI, Belousova EA, Samolygo IS, Manina MA, Kondrashova PV, Lomakina EY, Kardonsky DA, Vorobyeva EA, Shagaleeva OY, Silantyev AA, Kazakova VD, Kashatnikova DA, Kalachnuk TN, Kolesnikova IV, Chaplin AV, Markelova MI, Grigoryeva TV, Olekhnovich EI, Veselovsky VA, Morozov MD, Zoruk PY, Boldyreva DI, Vanyushkina AA, Efimov BA. Combined metabolomic and metagenomic analysis reveals inflammatory bowel disease diversity in pediatric and adult patients. World J Gastroenterol 2025; 31(48): 112653
- URL: https://www.wjgnet.com/1007-9327/full/v31/i48/112653.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i48.112653